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The TATA-binding protein (TBP) nucleates the assembly and determines the position of the preinitiation
complex at RNA polymerase II-transcribed genes. We investigated the importance of two conserved residues on
the DNA binding surface of Saccharomyces cerevisiae TBP to DNA binding and sequence discrimination.
Because they deﬁne a signiﬁcant break in the twofold symmetry of the TBP-TATA interface, Ala100 and Pro191
have been proposed to be key determinants of TBP binding orientation and transcription directionality. In
contrast to previous predictions, we found that substitution of an alanine for Pro191 did not allow recognition
of a reversed TATA box in vivo; however, the reciprocal change, Ala100 to proline, resulted in efﬁcient
utilization of this and other variant TATA sequences. In vitro assays demonstrated that TBP mutants with the
A100P and P191A substitutions have increased and decreased afﬁnity for DNA, respectively. The TATA binding
defect of TBP with the P191A mutation could be intragenically suppressed by the A100P substitution. Our
results suggest that Ala100 and Pro191 are important for DNA binding and sequence recognition by TBP, that
the naturally occurring asymmetry of Ala100 and Pro191 is not essential for function, and that a single amino
acid change in TBP can lead to elevated DNA binding afﬁnity and recognition of a reversed TATA sequence.
Transcription of protein-encoding genes in eukaryotes re-
quires the assembly of a large, multiprotein complex at the
promoter. This preinitiation complex contains RNA polymer-
ase II, six different general transcription factors (TFIIA,
TFIIB, TFIID, TFIIE, TFIIF, and TFIIH), and a large number
of accessory proteins that mediate the response to transcrip-
tional activators and repressors (46). Of these proteins, TFIID
is unique in its ability to bind DNA in a sequence-speciﬁc
manner in the absence of other members of the preinitiation
complex. Sequence recognition by TFIID is directed by the
TATA binding protein (TBP) subunit. As the initial step in the
assembly of the preinitiation complex, the binding of TFIID to
the TATA box is a highly regulated event. In vivo and in vitro
studies have shown that many transcriptional activators stim-
ulate transcription by facilitating the rate-limiting binding of
TFIID to the TATA box (35, 41, 48, 50, 67, 79), while certain
transcriptional repressors, including histones, impede this step
(4, 36, 41, 83).
As the central component of the general transcription ma-
chinery, the TBP-TATA box complex has been the subject of
intense study. Computational studies have identiﬁed an 8-bp
consensus sequence for the TATA box [TATA(A/T)A(A/T)N]
(9). The importance of this sequence for transcriptional activ-
ity has been conﬁrmed by systematic mutational studies (14,
25, 82). These previous experiments, along with crystallo-
graphic analyses (62), have demonstrated that base substitu-
tions in the 5 half of the consensus sequence are particularly
detrimental to binding by TBP. X-ray crystal structures have
been solved for TBP-TATA complexes from diverse species
and indicate a remarkable degree of conservation (20, 30,
32–34, 38, 51, 58, 59, 62, 77, 78). In each of these structures, the
highly conserved carboxy-terminal core domain of TBP binds
the 8-bp TATA sequence as a saddle-shaped molecule with a
high degree of pseudodyad symmetry. The symmetry between
the two subdomains of the saddle derives from two imperfect,
direct repeats that dominate the TBP core domain. TBP binds
the TATA box exclusively through minor-groove contacts that
are predominantly hydrophobic in nature and by causing a
dramatic distortion of the DNA.
For successful transcription of a gene, the preinitiation com-
plex must assemble at the promoter in a way that leads to a
properly positioned and oriented RNA polymerase II. X-ray
crystallographic studies of all eukaryotic TBP-TATA com-
plexes revealed a unique binding orientation for TBP in which
the carboxy-terminal subdomain of the TBP saddle contacts
the 5 half of the TATA box and the amino-terminal subdo-
main contacts the 3 half of the TATA box (20, 30, 32–34, 58,
59, 62, 77, 78). This orientation has also been observed in vivo
(3) and is required for the directional assembly of the preini-
tiation complex and transcription initiation (20, 59, 77, 78).
Because of the approximately twofold rotational symmetry of
TBP and certain TATA sequences, the underlying basis for the
observed orientation remains unclear. Molecular dynamics
studies have revealed no unfavorable contacts if TBP is forced
to bind in the opposite orientation (55), and there is very little
chemical distinction between a T  A base pair and an A  T
base pair in the minor groove (71). In fact, experiments de-
signed to assess the directionality of TBP binding on the ade-
novirus major late promoter (AdMLP) TATA box and the
Saccharomyces cerevisiae CYC1 TATA box in solution have
demonstrated that TBP is capable of bidirectional binding in
vitro but still exhibits a modest preference (60:40 ratio) for the
orientation observed in the crystal structures (16). Addition of
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8744TFIIA and TFIIB signiﬁcantly increases the preference (to
approximately 95%) for the “correct” orientation (31).
Several hypotheses invoking the intrinsic properties of TBP
and the TATA box have been proposed to explain the binding
orientation detected by crystallography and preferred in solu-
tion. The proposed sources of directional binding include
asymmetric deformability of the two subdomains of TBP and
the two halves of the TATA box (22, 32, 34, 62, 76), small
electrostatic charge differences between the DNA binding sur-
faces of the TBP subdomains (34), and slight breaks in the
symmetry of the amino acid-base contacts along the TBP-DNA
interface (30, 33). One prominent break in the pseudodyad
symmetry of the TBP-DNA interface involves a highly con-
served proline residue, Pro191 of yeast TBP, which directly
contacts base A1 of the TATA box (position A1 denotes the
Ao ft h eﬁrst T  A base pair) (Fig. 1) (30, 32–34, 58, 62). The
side chain of the equivalently positioned residue in the amino-
terminal repeat, Ala100, makes no contact with the 3 end of
the TATA box. Juo et al. proposed that this proline-alanine
asymmetry plays a dominant role in establishing the binding
orientation of TBP (30). According to the “proline clash” hy-
pothesis, Pro191 effectively determines binding orientation be-
cause its side chain would sterically clash with bases other than
an A at position 1 (30). The small side chain of alanine
imposes no restrictions on base pair 8, and therefore this po-
sition of the TATA sequence is the least well conserved.
To test the importance of Pro191 in dictating TBP binding
orientation, we mutated this residue to an alanine and tested
the ability of the mutant TBP (TBP-P191A), to direct tran-
scription in vivo from a TATA sequence of reversed orienta-
tion. We also generated a TBP mutant with the reciprocal
change, A100P (TBP-A100P). Our results suggest that Pro191
and Ala100 inﬂuence TATA box recognition by TBP, although
not by the mechanism proposed. Whereas TBP-A100P efﬁ-
ciently utilized the reversed TATA sequence, TBP-P191A did
not. We show that a TBP mutant, TBP-A100P, with two pro-
lines on the DNA binding surface functions dominantly to
wild-type TBP, has increased afﬁnity for DNA in vitro, and
efﬁciently directs transcription from core promoter and variant
TATA sequences, including a reversed TATA sequence, in
vivo.
MATERIALS AND METHODS
Media and yeast strains. The S. cerevisiae strains used in this study are listed
in Table 1. All KY strains were derived from FY2 (MAT ura3-52), a GAL2

derivative of S288C (81). Standard methods of mating, sporulation, tetrad dis-
section, and transformation were used (68). Rich medium (yeast extract-pep-
tone-dextrose), synthetic complete (SC) medium, and synthetic minimal (SD)
medium were made as described previously (68). YPSuc medium contained 2%
sucrose and 1 g of antimycin A/ml. The aminotriazole media included SD
medium with the indicated concentrations of 3-amino-1,2,4-triazole (AT; Sigma)
and all necessary amino acids.
Yeast strains containing variant HIS3 promoters were constructed as previ-
ously described (3, 25). Brieﬂy, complementary pairs of oligonucleotides (Table
2) were designed to contain the desired TATA box, its ﬂanking sequence, and
terminal 5 EcoRI and 3 SacI restriction sites. After annealing, the duplex
fragment was inserted at the EcoRI and SacI sites of a URA3-marked, integrating
plasmid, thereby replacing the regulatory TATA sequence upstream of the HIS3
gene. The constitutive HIS3 TATA element had been deleted in these con-
structs; however, the Gcn4 binding site and poly(dA-dT) sequence were retained.
FIG. 1. X-ray crystal structure of yeast TBP (top panel). The posi-
tions of Ala100 and Pro191 are indicated. The ﬁgure was adapted from
reference 34. Space-ﬁlling representations of the TBP-DNA interface
near Ala100 (bottom left panel) and Pro191 (bottom right panel). TBP
is shown as a tube, except for the indicated amino acid side chains. This
image was generated using publicly available computer software
(http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml).
TABLE 1. S. cerevisiae strains
Strain Genotype
a
KY423 ......................................................MATa his3-200 ura3-52 trp163
KY430 ......................................................MATa his3-250(CTTTTATAG) trp163 ura3-52
KY787 ......................................................MAT his3-250(CTTTTATAG) lys2-128 leu21 ura3-52 trp163 spt15102::LEU2 [pDE28-6]
KY788 ......................................................MAT his3-250(CTTTTATAG) lys2-128 leu21 ura3-52 trp163
KY789 ......................................................MATa his3-252(CATAAAAG) trp163 ura3-52
KY790 ......................................................MATa his3-251(TATAAAAG) trp163 ura3-52
KY791 ......................................................MATa his3-253(TATAAGAG) trp163 ura3-52
KY792 ......................................................MATa his3-254 (TATAATAG) trp163 ura3-52
KY793 ......................................................MATa his3-250(CTTTTATAG) ura3-52 trp163 SPT15 (HA3-TBP)
KY794 ......................................................MATa his3-255(TATAGGGT) trp163 ura3-52
YY1..........................................................MAT his4-917 lys2-128 leu21 ura3-52 trp163 suc2UAS(1900/390) spt15102::LEU2 [pDE28-6]
a his3 alleles 250 to 255 have variant TATA elements, shown in parentheses, directing transcription of a wild-type IIIS3 open reading frame. These promoter mutants
are integrated at the normal HIS3 locus, replacing the wild-type gene.
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stream of the Gcn4 binding site and 83 bp upstream of the transcription initiation
site. Plasmids were conﬁrmed by DNA sequencing, linearized with XbaI, and
transformed into KY423. After a two-step gene replacement (70), His
 recom-
binants were identiﬁed and proper integration of the plasmid was conﬁrmed by
Southern analysis. The following oligonucleotides (Table 2) and integrating
plasmids were used to generate strains harboring variant HIS3 promoters (the
top strand of the 8-bp TATA box is indicated from 5 to 3): CTTTTATA
(his3-250), KA141, KA142, and pJVS83; TATAAAAG (his3-251), JVS50,
JVS51, and pJVS73; CATAAAAG (his3-252), JVS44, JVS45, and pJVS66;
TATAAGAG (his3-253), JVS54, JVS55, and pJVS75; TATAATAG (his3-254),
JVS56, JVS57, and pJVS76; and TATAGGGT (his3-255), JVS62, JVS63, and
pJVS82. The sequences ﬂanking the different TATA elements are identical
(Table 2).
Plasmid construction. Plasmid construction was performed using standard
cloning techniques (5). Plasmids pJVS47 (for TBP-A100P) and pJVS48 (for
TBP-P191A) were made by site-directed mutagenesis of plasmid pDE28-6 (19)
by use of a Bio-Rad Muta-Gene kit and oligonucleotides JVS32 and JVS33
(Table 2), respectively. pDE28-6 contains the 2.4-kb EcoRI-BamHI fragment
of SPT15 cloned into the EcoRI-BamHI sites of pRS316 (72). pJVS53 (for the
TBP mutant with the A100P and P191A substitutions [TBP-A100P, P191A]) was
made by inserting the 800-bp AgeI-BamHI fragment of pJVS48 into pJVS47,
thereby replacing the wild-type AgeI-BamHI fragment. pJVS49, pJVS50, and
pJVS54 were made by cloning the 2.4-kb EcoRI-BamHI fragments of pJVS47,
pJVS48, and pJVS53, respectively, into the same sites of pRS314 (72). Plasmid
pKA75 contains the 2.4-kb EcoRI-BamHI fragment of SPT15 cloned into a
derivative of pRS314 that lacks the polylinker SpeI site. pJVS77, used to express
TBP-A100P in Escherichia coli, was made by insertion of an 400-bp, PCR-
generated NdeI-AgeI fragment from pJVS49 into the NdeI-AgeI sites of pKA9
(1), thereby replacing the wild-type sequence. pKA9 contains wild-type SPT15
cloned into the NdeI and BamHI sites of plasmid pET-3b (Stratagene). pJVS80
and pJVS81, used to express TBP-P191A and TBP-A100P, P191A, were made by
cloning the AgeI-BamHI fragment of pJVS50 into the AgeI and BamHI sites of
pKA9 and pJVS77, respectively, thereby replacing the wild-type sequences.
Yeast growth assays. Transformants containing the indicated plasmids were
grown at 30°C to saturation in the appropriate selective medium. Cells were
washed twice, resuspended in sterile water to a concentration of 10
8 cells/ml, and
serially diluted as indicated in the ﬁgure legends. Three microliters of each serial
dilution was spotted by pipetting onto the indicated solid medium. Plates were
incubated at 30°C for the indicated times.
S1 nuclease protection assays. KY788 was transformed with plasmids
pDE28-6, pJVS47, pJVS48, and pJVS53, and transformants were grown to a
concentration of 1 	 10
7 to 2 	 10
7 cells/ml in 100 ml of SD medium lacking
histidine and uracil (ura). Cells were harvested, washed twice with sterile water,
and frozen at 70°C prior to RNA isolation. RNA was isolated by glass bead
lysis and phenol extraction (12). S1 nuclease protection assays were performed
using 5-end-labeled oligonucleotides JVS22 (SNR6), KA123 (HIS3), and KA124
(DED1) (Table 2) as described previously (27).
Protein puriﬁcation and DNA binding assays. TBP, TBP-A100P, TBP-P191A,
and TBP-A100P, P191A were puriﬁed from E. coli BL21(DE3) expression
strains essentially as described previously (64). In all cases, the TBPs were
approximately 95% pure, as judged by Coomassie blue staining of sodium do-
decyl sulfate (SDS)-acrylamide gels. DNase I protection and electrophoretic
mobility shift assays (EMSAs) were performed with a
32P-labeled DNA probe
from plasmid pRW and containing the AdMLP TATA box as described previ-
ously (10, 18).
Ethylation interference footprinting was performed as described previously
(47). Brieﬂy, 5 nmol of complementary oligonucleotides JVS58 and JVS59 (Ta-
ble 2) were individually ethylated in 200-l reaction mixtures with 100 mg of
N-ethyl-N-nitrosourea (Sigma)/ml in 25 mM cacodylate, pH 8.0. A 200-mg/ml
stock solution of N-ethyl-N-nitrosourea was prepared in 100% ethanol. After
ethylation, the DNA was dialyzed into water and then end labeled using T4
polynucleotide kinase and [
-
32P]ATP. Ethylated, kinased oligonucleotides were
puriﬁed over NENSORB columns (DuPont) according to the manufacturer’s
directions. Complementary oligonucleotides, only one of which was ethylated
and radiolabeled, were annealed in 20-l reaction mixtures containing 0.2 M
NaCl and 10 mM Tris-Cl, pH 7.5, by heating the reaction mixtures in a water bath
to 95°C for 30 min and then allowing them to cool slowly overnight. EMSAs were
performed with bacterially expressed wild-type and mutant TBPs as described
above. Bands corresponding to bound and unbound DNA were excised from the
gel, and the DNA was eluted in 10 M urea and puriﬁed over NENSORB
columns. Cleavage of the DNA was carried out in 10 mM sodium phosphate (pH
7.0)–1 mM EDTA–150 mM NaOH at 90°C for 30 min. After cleavage, the
oligonucleotides were analyzed on a 20% polyacrylamide–8.3 M urea sequencing
gel with a 2-in. 8% polyacrylamide–8.3 M urea cushion.
-galactosidase assays. Strain KY787 was transformed with plasmids pKA75
(SPT15
/TRP1/CEN/ARS [2]) and pJVS49, and Trp
 transformants were se-
lected, puriﬁed, and streaked to medium containing 5-ﬂuoroorotic acid (5-FOA)
to select against the pDE28-6 plasmid. The resulting Ura
 strains were trans-
formed with one of the following URA3-marked lacZ reporter plasmids: pLG-
178 (cyc1UAS-lacZ [23]), pLG669-Z (CYC1-lacZ [24]), pM740 (hoUAS-lacZ
[29]), and p1701 (HO-lacZ; obtained from David Stillman). Transformants were
grown to a concentration of 1 	 10
7 to 2 	 10
7 cells/ml in SC medium lacking
uracil and tryptophan (SC-ura-Trp). Cells were harvested, extracts were pre-
pared, and -galactosidase assays were performed as described previously (56,
65). Protein concentrations were determined by the method of Bradford (8).
-galactosidase unit calculations were done as described previously (56).
TABLE 2. Oligonucleotides
Name Sequence (5 to 3)
KA123.................GGTTCCATTTGTAATACGGCTTTACTAGGGCTTTCTGCTCTGTCATCTTTGCCTTCGTTTATCTTGCCTGCTCATTT
KA124.................GCTAAAGAAGCTGCCACCGCCACGGCCACCGTTGTAGCCGCGTAG
KA141.................AATTCCCTTTTATAGGGTGGAGCT
KA142.................CCACCTATAAAAAGGG
JVS22..................CTTTGTAAAACGGTTATCCTTATGCAGGGGAACTGCTGATCATCTCTGTATTGTTTCAA
JVS32..................GCATGATGACAGCTGGAAAACGCTTGG
JVS33..................TAGATCAAACCAGCAAACAATTCTG
JVS44..................AATTCCCCATAAAAGGGTGGAGCT
JVS45..................CCACCCTTTTATGGGG
JVS50..................AATTCCCTATAAAAGGGTGGAGCT
JVS51..................CCACCCTTTTATAGGG
JVS54..................AATTCCCTATAAGAGGGTGGAGCT
JVS55..................CCACCCTCTTATAGGG
JVS56..................AATTCCCTATAATAGGGTGGAGCT
JVS57..................CCACCCTATTATAGGG
JVS58..................GGAATTCCCTTTTATAGGGTGGAGCT
JVS59..................AGCTCCACCCTATATAAAAGGGAATTCC
JVS62..................AATTATTCCCTATAGGGTGGAGCT
JVS63..................CCACCCTATAGGGAAT
JVS64..................GGAATTCCCT
JVS65..................GGAATTCCCTTTT
JVS66..................GGAATTCCCTTTTATAG
JVS67..................GGAATTCCCTTTTATAGGGTGGA
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pDE28-6, pJVS47, pJVS48, or pJVS53 were grown at 30°C to a concentration of
3 	 10
7 to 6 	 10
7 cells/ml in SC-ura medium. Whole-cell extracts were
prepared by glass bead lysis as described previously (74). Protein extract derived
from 10
7 cells was loaded in each lane of an SDS–15% polyacrylamide gel.
Following electrophoresis, proteins were transferred to nitrocellulose and pro-
cessed by standard procedures for immunoblotting (26). Anti-TBP polyclonal
antiserum was the gift of Steve Buratowski. The secondary antibody was donkey
anti-rabbit immunoglobulin G conjugated to horseradish peroxidase (Amer-
sham). Immunoblots were developed with a chemiluminescent detection system
(Pierce). Plasmid-expressed TBP levels were quantitated relative to HA3-TBP
levels by using NIH Image, a public-domain computer program (developed by
the National Institutes of Health and available at http://rsb.info.nih.gov/nih-
image/).
Mot1 and TAND interaction assays. Experiments to test the ability of puriﬁed
Mot1 (provided by David Auble) to disrupt TBP-DNA complexes were per-
formed with reaction mixtures containing 2 ng of wild-type or mutant TBP and
the TATA-containing
32P-labeled probe from pRW as described previously (17).
Where indicated, ATP was added to a ﬁnal concentration of 5 M. Glutathione
S-transferase (GST)–Taf1 N-terminal domain (TAND) fusion proteins were
expressed in E. coli from previously described plasmids (37) and prepared and
quantitated by published procedures (39). GST pull-down assays were performed
as described previously (39).
RESULTS
TBP-A100P directs transcription from a reversed TATA
box. To test the involvement of Pro191 and Ala100 of yeast
TBP in the regulation of the directionality of transcription,
plasmids expressing TBP-P191A, TBP-A100P, and the double
mutant TBP-A100P, P191A were transformed into the yeast
strain KY788. In this strain, transcription of the chromosomal
HIS3 gene is driven by a TATA box of reversed orientation
(RTATA box) with the sequence 5CCCTTTTATAGGG3
(the underlined sequence denotes the reversed orientation of a
consensus TATA box, TATAAAAG). Recognition of the
RTATA sequence maintains the transcriptionally relevant ori-
entation of TBP with respect to the HIS3 gene (Fig. 2), a
requirement imposed by the asymmetric positioning of the
other general transcription factors in the preinitiation complex
(20, 59, 77, 78). In vivo recognition of the RTATA sequence
was measured as the resistance of the yeast strains to AT, a
competitive inhibitor of the HIS3 gene product. As expected
from the results of previous studies (57, 60, 80), wild-type TBP
utilized the RTATA box poorly, leading to only weak growth
on medium containing 10 mM AT (Fig. 3A). Relative to a
consensus TATA box and independent of the exact positioning
of TBP on the sequence, the RTATA element contains mul-
tiple-base substitutions that individually compromise transcrip-
tion in vitro and in vivo (14, 25, 82). A strain expressing TBP-
P191A exhibited a similar level of AT resistance, suggesting
that TBP-P191A was no better than wild-type TBP at recog-
nizing the RTATA sequence (Fig. 3A). Surprisingly, the recip-
rocal change, Ala100 to Pro, led to a signiﬁcant increase in
RTATA box usage, as measured by increased AT resistance
(Fig. 3A). The doubly mutated protein, TBP-A100P, P191A,
supported an intermediate level of RTATA box usage relative
to the single mutants (Fig. 3A). Since KY788 contains a chro-
mosomal copy of the wild-type SPT15 gene, TBP-A100P acts
dominantly in its ability to use the RTATA sequence. Strains
expressing TBP-A100P alone exhibited a level of AT resistance
similar to those of strains expressing both wild-type TBP and
TBP-A100P as well as several other mutant phenotypes that
were comparatively weak (data not shown). These additional
phenotypes included slightly impaired growth on galactose,
sucrose, and rafﬁnose media and weak temperature sensitivity
for growth at 37°C.
To conﬁrm and quantify the transcriptional effect at HIS3,
S1 nuclease protection assays were performed on strains that
express the TBP mutants in the presence of endogenous wild-
type TBP. RNA was prepared from cells that were grown in SD
medium that maintained selection for the TBP-expressing
plasmid. Relative to a strain expressing only wild-type TBP, a
strain expressing TBP-A100P showed a twofold increase in
HIS3 mRNA levels, providing a transcriptional explanation for
the increased AT resistance (Fig. 3B). Strains expressing TBP-
P191A and TBP-A100P, P191A showed HIS3 mRNA levels
that were comparable to and 1.3-fold higher than that of the
wild type, respectively. DED1, a constitutively expressed RNA
polymerase II transcript, and SNR6, a stable RNA polymerase
III transcript, were used as internal loading controls for this
experiment (Fig. 3B and data not shown). Taken together with
our phenotypic results, these data suggest that Pro191 and
Ala100 contribute in important ways to TATA site recognition.
To address the possibility that altered TBP levels were af-
fecting TATA utilization, Western blot analysis of strains ex-
pressing a chromosomal HA3-tagged version of wild-type TBP
and a plasmid-expressed copy of TBP, TBP-A100P, TBP-
P191A, or TBP-A100P, P191A was performed. These strains
showed no signiﬁcant difference in TBP levels (Fig. 3C). In
addition, overexpression of wild-type TBP from a 2-m plas-
mid in an RTATA-HIS3 strain did not lead to a level of AT
resistance greater than that of the vector control strain (data
not shown). These results indicate that TBP levels do not play
FIG. 2. HIS3 reporter constructs used in the analysis of TBP bind-
ing directionality. (A) Diagram of the TATA-HIS3 construct in which
the AdMLP 8-bp TATA box, shown in bold, was inserted upstream of
the yeast HIS3 gene as described in Materials and Methods. The
orientation of TBP needed for HIS3 transcription is shown. (B) Dia-
gram of the RTATA-HIS3 construct containing an inverted AdMLP
TATA sequence, shown in bold. The predicted binding orientation of
a mutant TBP able to direct transcription from the RTATA sequence
is shown. Notice that this orientation would support the assembly of
the remaining general transcription factors and RNA polymerase II in
a manner necessary for HIS3 transcription. C and N refer to the
carboxy- and amino-terminal subdomains of the TBP saddle, respec-
tively.
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reporter.
TBP-A100P does not recognize a cryptic TATA box within
the RTATA sequence. Embedded in the RTATA sequence is a
potentially cryptic TATA box (CTTTTATAGGGT). The 5
end of this element contains the consensus TATA sequence,
while the 3 end differs extensively from the preferred AAAN.
However, the deformability of the 5 end of the TATA box has
been proposed as a key determinant of TBP binding direction-
ality (22), and binding of yeast TBP to a similar nonconsensus
TATA box, TATAGGTG, has been observed in vitro (49).
Therefore, we used two different strategies to investigate the
possibility that TBP-A100P recognized this sequence instead
of the RTATA box. First, we substituted the sequence CTAT-
AGGGTG for the RTATA sequence upstream of the HIS3
gene and assayed expression of this reporter gene by growth of
yeast strains on AT medium. The sensitivity of this in vivo test
is high, because transcription from a very poor TATA box can
be detected as growth on low concentrations of AT (25, 82). As
shown in Fig. 4A, neither TBP nor TBP-A100P used this
TATA sequence sufﬁciently to allow growth on 10 mM AT.
This ﬁnding contrasts with the results of our experiments in-
volving the full RTATA box construct (Fig. 3A) and strongly
suggests that TBP-A100P recognizes the RTATA sequence.
To determine the precise position of TBP on an RTATA-
containing DNA probe, we performed ethylation interference
footprinting with recombinant TBP and TBP-A100P. Comple-
mentary 26mer oligonucleotides, JVS58 and JVS59, encoding
the RTATA sequence, CTTTTATAG, were individually ethy-
lated and radiolabeled as described in Materials and Methods.
Ethylation of phosphate groups that are critical for the TBP-
TATA interaction prevents binding by TBP, and the corre-
sponding DNA fragments are excluded from the TBP-bound
population of an EMSA. Since the ethyl groups project about
4.5 A ˚ from the phosphate (54), this procedure allows ﬁne
structure mapping of the TBP-TATA complex. The position of
the ethylation interference footprint of TBP-A100P on both
strands was similar to that of wild-type TBP (Fig. 4B and data
not shown), indicating that both proteins protected the same
DNA sequence, CTTTTATA. Taken together, these data sug-
gest that TBP-A100P recognizes and directs transcription from
a reversed TATA sequence in vivo.
TBP-A100P directs transcription from several variant
TATA sequences. We also tested TBP-A100P for its ability to
recognize other near-consensus TATA boxes. Plasmids encod-
ing TBP and TBP-A100P were transformed into strains that
expressed an endogenous, wild-type copy of SPT15 and a HIS3
gene that was driven by one of three variant TATA boxes,
CATAAAAG, TATAAGAG, or TATAATAG. In previous
studies of wild-type TBP, similar TATA boxes supported a
range of in vitro transcription activities from approximately
10% (TATAATGT) to 30% (CATAAAGT) to 58% (TATA-
AGGT) relative to TATAAAGT (82). For all of the sequences
tested, TBP-A100P supported a higher level of HIS3 expres-
sion than did wild-type TBP (Fig. 5). Similar results were
observed for variant TATA boxes in two different ﬂanking
sequence contexts (data not shown). These results suggest that
usage of the RTATA sequence by TBP-A100P stems from a
general change in TBP activity rather than from a speciﬁc and
restricted alteration in sequence recognition.
FIG. 3. TBP-A100P directs transcription from an RTATA box in
vivo. (A) Strain KY788, which contains the integrated RTATA-HIS3
reporter, was transformed with CEN/ARS plasmid pDE28-6 (TBP),
pJVS47 (TBP-A100P), pJVS48 (TBP-P191A), or pJVS53 (TBP-
A100P, P191A) and spotted onto selective plates (SD-his-ura) contain-
ing or lacking 10 mM AT. Plates were incubated at 30°C for 4 days.
The endogenous SPT15 gene, expressing wild-type TBP, is present in
each of these strains. (B) S1 nuclease protection analysis of HIS3 and
DED1 mRNA levels in the transformed strains shown in panel A. The
levels of HIS3 mRNA were quantitated using a phosphorimager and
normalized to the DED1 mRNA levels. Values are reported relative to
the amount of HIS3 mRNA in the transformant expressing only wild-
type TBP and represent averages from two experiments. (C) Immu-
noblot analysis of TBP levels in transformants of strain KY793 con-
taining the CEN/ARS plasmid pDE28-6 (TBP), pJVS47 (TBP-A100P),
pJVS48 (TBP-P191A), or pJVS53 (TBP-A100P, P191A). The strains
also expressed an HA3-tagged form of wild-type TBP from the chro-
mosomal SPT15 locus. Asterisks indicate nonspeciﬁc bands. Mutant
TBPs containing the A100P substitution reproducibly exhibited an
altered mobility relative to that of wild-type TBP.
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ﬁnity of TBP. Since the A100P and P191A substitutions change
residues on the DNA binding surface of TBP (32–34), we
explored the possibility that the in vivo effects of the TBP
mutants were due to an alteration in DNA binding. To test the
DNA binding activities of the mutant TBPs, DNase I footprint-
ing and EMSAs were performed with bacterially expressed and
puriﬁed TBP, TBP-A100P, TBP-P191A, and TBP-A100P,
P191A. A probe containing the AdMLP TATA box (TATA-
AAAG) was used in these experiments. Quantitation of the
DNase I footprinting and EMSA results showed that TBP-
A100P had approximately twofold higher afﬁnity for the
TATA-containing probe than did wild-type TBP (Fig. 6 and
data not shown). In contrast, TBP-P191A exhibited a striking
defect in TATA box binding, indicating that this highly con-
served proline residue plays a critical role in the formation or
stabilization of the TBP-TATA complex (Fig. 7A). X-ray crys-
tallographic studies have demonstrated that proline 191 in
yeast TBP makes direct contact with the TATA box (Fig. 1)
(32–34). Addition of recombinant TFIIA strongly suppressed
the DNA binding defect of TBP-P191A, indicating that the
recombinant protein was not denatured or otherwise rendered
inactive by our puriﬁcation procedure (data not shown). Sim-
ilar suppressive effects of TFIIA have been reported for other
TBP mutants defective in DNA binding (43, 52). Like several
previously described TBP mutants (2, 45), TBP-P191A sup-
ports viability despite a severe TATA box binding defect in
vitro. Interestingly, the double-mutant protein, TBP-A100P,
P191A, bound the AdMLP TATA probe with nearly wild-type
afﬁnity (Fig. 7B). Therefore, replacement of Ala100 with a
FIG. 4. TBP-A100P does not use a cryptic TATA box within the
RTATA promoter. (A) A HIS3 gene driven by the sequence TAT-
AGGGT was integrated at the chromosomal HIS3 locus to generate
strain KY794 as described in Materials and Methods. KY794 was
transformed with plasmids pKA75 and pJVS49 expressing TBP and
TBP-A100P, respectively. Two independent transformants for each
plasmid were replica plated to selective medium containing 0 or 10
mM AT. Plates were photographed after 2 days of incubation at 30°C.
Longer times of incubation did not lead to signiﬁcant levels of growth
or reveal differences between the transformants. (B) Ethylation inter-
ference footprints of TBP and TBP-A100P on the RTATA box se-
quence. Oligonucleotide JVS58 (Table 2) was ethylated, radiolabeled,
and annealed to oligonucleotide JVS59. Recombinant TBP or TBP-
A100P was incubated with the annealed probe, and the reaction mix-
tures were resolved by EMSA. DNA fragments from the TBP-bound
(B) and unbound (U) populations were excised from the EMSA gel,
eluted, and cleaved as described in Materials and Methods. Products
FIG. 5. TBP-A100P directs expression from several variant TATA
boxes in vivo. Strains KY430, KY789, KY790, KY791, and KY792,
containing the indicated TATA boxes upstream of HIS3, were trans-
formed with CEN/ARS plasmids expressing TBP (pDE28-6) or TBP-
A100P (pJVS47). Transformants were spotted onto selective plates
(SD-his-ura) containing or lacking 20 mM AT. This concentration of
AT was used to distinguish the effects of the variant TATA elements.
Plates were incubated at 30°C for 2 days prior to photography.
of the cleavage were resolved on a denaturing 20% polyacrylamide gel.
Lane 2 contains the cleavage products of a naked DNA sample. Lane
1 contains
32P-labeled oligonucleotide size markers JVS67 (A; 23 nu-
cleotides [nt]), JVS66 (B; 17 nt), JVS65 (C; 13 nt), and JVS64 (D; 10
nt).
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fect of TBP-P191A. These results indicate that the presence of
a proline at either position 100 or 191 and an alanine at the
other position is sufﬁcient for wild-type levels of DNA binding
in vitro.
TBP-A100P confers a Bur
 phenotype but interacts with the
negative regulators Mot1 and TAND. In genetic screens and
selections for mutations that bypass the transcriptional re-
quirement for an upstream activation sequence (Bur
 pheno-
type), mutations in several genes related to TBP function,
including SPT15 itself, have been identiﬁed (11, 65, 66). In-
cluded among these genes are those that encode inhibitors of
the TBP-TATA interaction, such as histones and Mot1. TBP-
A100P has increased afﬁnity for TATA-containing DNA in
vitro and could potentially counter the effects of these negative
regulators in vivo. Therefore, we tested whether TBP-A100P
could bypass the transcriptional requirement for the upstream
activation sequences of SUC2, CYC1, and HO.
TRP1-marked plasmids expressing wild-type TBP and TBP-
A100P were transformed into strain YY1 which contains a
chromosomal copy of SUC2, suc2UAS(1900/390), lacking
1,500 bp from, the SUC2 promoter, including the entire UAS
(11, 69). A URA3-marked plasmid expressing wild-type TBP
was evicted from these transformants by growth on medium
containing 5-FOA. Expression of the suc2UAS gene was mea-
sured as growth on medium containing sucrose as the sole
carbon source. As shown in Fig. 8A, strains containing wild-
type TBP failed to grow on sucrose media. Previous studies
FIG. 6. TBP-A100P has increased afﬁnity for DNA in vitro.
(A) EMSA of binding of recombinant wild-type TBP and TBP-A100P
to an AdMLP TATA box probe. Reaction mixtures for lanes 2 to 7
contained wild-type TBP, and those for lanes 9 to 14 contained TBP-
A100P. The amounts of TBP in the reaction mixtures were as follows:
0 ng, lanes 1 and 8; 0.25 ng, lanes 2 and 9; 0.50 ng, lanes 3 and 10; 1.0
ng, lanes 4 and 11; 2.0 ng, lanes 5 and 12; 4 ng, lanes 6 and 13; and 8
ng, lanes 7 and 14. (B) DNase I footprinting assay of binding of
recombinant wild-type TBP and TBP-A100P to an AdMLP TATA box
probe. Reaction mixtures for lanes 4 to 10 contained wild-type TBP,
and those for lanes 12 to 18 contained TBP-A100P. The amounts of
TBP in the reaction mixtures were as follows: 0 ng, lanes 3 and 11; 4
ng, lanes 4 and 12; 8 ng, lanes 5 and 13; 16 ng, lanes 6 and 14; 32 ng,
lanes 7 and 15; 64 ng, lanes 8 and 16; 128 ng, lanes 9 and 17; and 256
ng, lanes 10 and 18. Lanes 1 and 2 contain the products of chemical
DNA sequencing reactions.
FIG. 7. TBP-P191A is defective for DNA binding, while TBP-
A100P, P191A shows nearly wild-type afﬁnity for DNA in vitro. DNase
I footprinting assay was used to measure the binding of recombinant
wild-type TBP, TBP-P191A (A), and TBP-A100P, P191A (B) to the
AdMLP TATA box. In each panel, reaction mixtures for lanes 4 to 10
contained wild-type TBP and those for lanes 12 to 18 contained mutant
TBP. The amounts of TBP in the reaction mixtures were as follows: 0
ng, lanes 3 and 11; 4 ng, lanes 4 and 12; 8 ng, lanes 5 and 13; 16 ng,
lanes 6 and 14; 32 ng, lanes 7 and 15; 64 ng, lanes 8 and 16; 128 ng,
lanes 9 and 17; and 256 ng, lanes 10 and 18. Lanes 1 and 2 contain the
products of chemical DNA sequencing reactions.
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 phenotype correlates with a dramatic
defect in SUC2 transcription (66). In contrast, a strain contain-
ing TBP-A100P and suc2UAS(1900/390) grew well on
sucrose media (Fig. 8A).
To test the ability of TBP-A100P to direct transcription from
other core promoters, plasmids bearing UAS-less derivatives
of the CYC1 and HO genes, cyc1UAS-lacZ and hoUAS-
lacZ, were transformed into strains containing wild-type TBP
or TBP-A100P as the sole TBP source, and the -galactosidase
levels were measured. TBP-A100P supported a small but sta-
tistically signiﬁcant increase in -galactosidase levels from both
reporter genes (Fig. 8B). Therefore, the increased DNA bind-
ing afﬁnity of TBP-A100P correlates with increased expression
from three different core promoters in vivo.
In two earlier studies, TBP mutants with amino acid substi-
tutions on the DNA binding surface were found to be defective
in supporting activated transcription (2, 45). Therefore, we
asked whether TBP-A100P also had an activation defect.
Strains expressing TBP and TBP-A100P were transformed
with CYC1-lacZ and HO-lacZ reporter plasmids containing
UAS elements and were assayed for -galactosidase activity.
TBP-A100P and TBP directed similar levels of expression for
both reporter genes, suggesting that TBP-A100P is not gener-
ally activation defective (Fig. 8C).
The ability of TBP-A100P to drive transcription from core
promoters and sub-optimal TATA sequences in vivo may arise
from several factors, not limited to the greater DNA binding
afﬁnity of the mutant TBP. For example, TBP-A100P might be
defective in its interaction with inhibitors of the TBP-TATA
interaction. We tested this possibility for two different negative
regulators, Mot1 and the TAND region of Taf1. Using the
energy provided by ATP hydrolysis, Mot1 can disrupt TBP-
TATA complexes and the products of this reaction can be
visualized by EMSA (4). In a manner dependent on ATP,
TBP-A100P–DNA complexes were as susceptible as wild-type
TBP-DNA complexes to disruption by Mot1, indicating that
Mot1 interacts effectively with the mutant TBP (Fig. 8D).
TAND has been shown to inhibit formation of the TBP-TATA
complex by interacting with amino acids on the DNA binding
surface of TBP (37). Using a GST pull-down assay, we found
that TBP and TBP-A100P interacted to approximately the
same extent with a GST-TAND derivative, GST-TAND(10-
88), which has previously been reported to bind TBP (Fig. 8E)
(37). Neither TBP nor TBP-A100P was able to interact with
GST alone (data not shown) or a truncated TAND derivative,
GST-TAND(10-58). Therefore, these results suggest that the
transcriptional effects of TBP-A100P in vivo are not due to
impaired interactions with at least two transcriptional repres-
sors, Mot1 and TAND.
DISCUSSION
Properties of the TBP-A100P and TBP-P191A mutants. In
this study, we investigated the importance of two highly con-
served amino acids in yeast TBP, Ala100 and Pro191, for
TATA box binding and discrimination. These two residues
occupy equivalent positions on the DNA binding surface of
TBP and represent one of the few breaks in the twofold sym-
metry of the TBP-DNA interface. Accordingly, these residues
were previously proposed to govern the binding orientation of
TBP and the directionality of transcription (30). By construct-
ing and analyzing TBP mutants in which Ala100 was changed
to a proline and Pro191 was changed to an alanine, we have
shown that these residues do indeed play important roles in
DNA binding and sequence recognition. However, contrary to
previous predictions (30), TBP-P191A cannot efﬁciently direct
transcription from a TATA box of reversed orientation. Sur-
prisingly, TBP-A100P can utilize the RTATA sequence and
several other variant TATA boxes with an efﬁciency greater
than that of the wild type. DNA binding assays and measure-
ments of transcription from core promoters strongly suggest
that TBP-A100P has increased afﬁnity for DNA in vivo.
TBP-A100P appears to represent a novel class of TBP point
mutant, having increased afﬁnity for a consensus TATA box
and relaxed speciﬁcity for a number of near-consensus TATA
sequences. While most previously described TBP mutants have
reduced activity, a number of gain-of-function mutants have
been reported (1, 7, 11, 21, 28, 75). Two studies have described
dominantly acting TBP mutants that speciﬁcally enhance tran-
scription from weak or repressed RNA polymerase II promot-
ers (7, 21). Unlike TBP-A100P, these mutants cannot support
cell viability when present as the only source of TBP and they
have reduced (21) or wild-type afﬁnity for DNA in vitro (7).
Other gain-of-function TBP mutants are disrupted in their
interactions with negative regulators of preinitiation complex
assembly (11) or in dimerization (28). Two mutants with al-
tered DNA binding speciﬁcity have been characterized (1, 75).
However, these mutants are not broadly relaxed in their se-
quence recognition properties and do not exhibit elevated af-
ﬁnity for consensus TATA sequences in vitro (1, 3, 75).
The increased DNA binding afﬁnity of TBP-A100P could
arise through several mechanisms that are not mutually exclu-
sive. Introduction of a proline side chain on the DNA binding
surface of TBP may create a new amino acid-base contact that
makes favorable energetic contributions to the stability of the
complex. Alternatively, the presence of a proline at position
100 may signiﬁcantly alter the conformation of the amino-
terminal TBP stirrup or the ability of TBP to bend the TATA
box. Ala100 is immediately preceded by Phe99, one of the two
phenylalanines that intercalate between base pairs 7 and 8 and
introduce a dramatic kink at the 3 end of the TATA box (34).
Since prolines are known to restrict the possible  and  angles
of the preceding amino acid (53), a proline at position 100
could signiﬁcantly impact, and perhaps favor, intercalation by
Phe99. Previous studies have demonstrated enhanced afﬁnity
of TBP for prebent DNA (61) and correlations between TATA
box bending and TBP-TATA complex stability (73) or tran-
scriptional activity (84).
The DNA binding surface of TBP also serves as the inter-
action site for proteins that regulate transcription. In particu-
lar, the TAND region of Taf1 and the mammalian counterpart
of Mot1, TAF170, have been shown to modulate the DNA
binding activity of TBP by interacting with amino acids on the
TBP-TATA interface (37, 63). While defective interactions
with these negative regulators could lead to increased tran-
scription from weak or core promoters by TBP-A100P, we
found that TBP-A100P interacted as well as wild-type TBP
with Mot1 and TAND in vitro. The DNA binding surface of
TBP can also engage in dimer formation with a second mole-
cule of TBP in a way that sequesters amino acids needed for
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cross-linking assay (15), we found that TBP-A100P and wild-
type TBP formed dimers at equivalent levels (data not shown).
Moreover, on the crystal structure of a TBP dimer, Ala100
does not participate directly in the TBP-TBP interaction (13).
While these results lead us to favor models in which the A100P
substitution directly inﬂuences TATA box binding or bending,
we cannot rule out the possibility that this substitution also
alters potential intramolecular interactions involving a domain
of TBP, such as the amino-terminal domain, that represses
DNA binding (40, 44) or interactions with other negative reg-
ulators in vivo.
Whereas the substitution of a proline for Ala100 signiﬁ-
cantly elevated the DNA binding afﬁnity of TBP, substitution
of an alanine for Pro191 had the opposite effect. TBP-P191A
was severely impaired in its ability to bind the AdMLP TATA
box in vitro and was unable to direct transcription from the
RTATA reporter in vivo. Crystallographic studies of TBP-
TATA complexes have shown that Pro191 makes direct con-
tact with the ﬁrst base pair of the TATA box (34). The reduced
DNA binding afﬁnity of TBP-P191A may simply arise from the
elimination of this contact. Alternatively, because Pro191 is
located immediately C terminal to Phe190, which together with
Phe207 intercalates between the ﬁrst two base pairs of the
TATA box (34), the P191A substitution may signiﬁcantly alter
the ability of TBP to bend the TATA box. Strikingly, the severe
DNA binding defect of TBP-P191A could be intragenically
suppressed by changing Ala100 to a proline. This result indi-
cates that TBP can bind a TATA box with near wild-type
afﬁnity if it contains a proline at either position 100 or 191 and
an alanine at the other position; the naturally occurring con-
ﬁguration is not essential for DNA binding (Fig. 7), transcrip-
tional activity in vivo (Fig. 3), or cell viability (data not shown).
Insights into directionality of TBP binding. Originally, we
were interested in testing the hypothesis that Pro191 positions
TBP on the TATA box in the proper orientation (30). Juo et al.
(30) postulated a dominant role for Pro191 in the establish-
ment of TBP binding orientation because of steric constraints
imposed by the proline side chain on interacting bases. Be-
cause the side chain of proline would sterically clash with the
functional groups of T, G, or C, the most energetically favor-
able situation places proline in contact with an A residue, as
observed for Pro191 and base A1. Replacement of this proline
with an alanine would be expected to eliminate these restric-
tions and lead to altered recognition of reversed and perhaps
other variant TATA elements. Surprisingly, the TBP-P191A
mutant protein exhibited no preference for the RTATA se-
quence relative to wild-type TBP in vivo and greatly reduced
afﬁnity for a consensus TATA element in vitro. Therefore,
instead of playing an entirely restrictive role in TATA box
FIG. 8. TBP-A100P bypasses the requirement for UAS elements.
(A) CEN/ARS plasmids expressing TBP (pKA75) or TBP-A100P
(pJVS49) were transformed into the suc2UAS strain YY1. Following
5-FOA-mediated eviction of the SPT15
-containing plasmid pDE28-6,
transformants were replica plated to YPSuc medium. Plates were in-
cubated at 30°C for 2 days prior to photography. (B and C) Strain
KY787 was transformed with plasmid expressing TBP (pKA75) or
TBP-A100P (pJVS49), and transformants were plated on 5-FOA me-
dium to evict plasmid pDE28-6. The resulting strains were transformed
with the reporter plasmid hoUAS-lacZ (p740), cyc1UAS-lacZ
(pLG-178), HO-lacZ (p1701), or CYC1-lacZ (pLG669-Z), as indi-
cated. Cultures were grown, and -galactosidase assays were per-
formed as described in Materials and Methods. Mean values of -ga-
lactosidase activity from three independent transformants assayed at
two different extract concentrations are presented. Hatched bars, wild-
type TBP; solid bars, TBP-A100P. Note the differences in scales. Stan-
dard errors were less than 15% of the mean and are depicted as error
bars. (D) Mot1 disruption of TBP-DNA complexes. TBP-DNA com-
plexes, containing wild-type TBP or TBP-A100P, were incubated with
Mot1 in the presence or absence of ATP as indicated. Reaction prod-
ucts were resolved by EMSA. (E) TBP-TAND interaction assay. GST
pull-down assays were performed with 30 pmol of wild-type TBP (lanes
1 to 4 and 9) or 30 pmol of TBP-A100P (lanes 5 to 8). GST-TAND
proteins were added in amounts of 30 (lanes 1 and 5), 45 (lanes 2 and
6), or 60 (lanes 3, 4, 7, and 8) pmol. Reaction products were resolved
by SDS-polyacrylamide gel electrophoresis and visualized by Coomas-
sie blue staining. The asterisk indicates a contaminating protein from
E. coli.
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100, is critical for promoting or stabilizing the TBP-TATA
interaction. Further, we observed signiﬁcant utilization of the
RTATA reporter only when prolines, not alanines, occupied
both positions 100 and 191. In effect, the A100P substitution
changed the amino-terminal subdomain of TBP to resemble
the carboxy-terminal subdomain in both sequence and func-
tion. Whether the proline introduced at position 100 also
makes direct contact with the TATA sequence is not known.
Moreover, since we do not know the exact positioning of TBP-
A100P on the RTATA sequence in vivo, we cannot readily
predict which base pair would be contacted by this proline or
whether this interaction establishes the binding register.
The TBP of the archaeal species Pyrococcus woesei naturally
contains two proline residues on its DNA binding surface at
positions analogous to 100 and 191 of S. cerevisiae TBP. Inter-
estingly, the ﬁrst crystal structure of P. woesei TBP that was
bound to its TATA-like sequence (box A) revealed a binding
orientation that was reversed relative to all known eukaryotic
TBP-TATA complex structures (38). Further analysis revealed
that the archaeal TFIIB orthologue, TFB, could reverse the
binding orientation of P. woesei TBP to that seen in the eu-
karyotic structures (51) and allow unidirectional transcription
(6). This effect was dependent on the presence of a TFB
recognition element, or BRE, on the DNA template immedi-
ately 5 to the TATA element. The BRE was originally iden-
tiﬁed as a recognition sequence for human TFIIB (42). Con-
sistent with these observations, solution studies of TBP binding
orientation demonstrated a signiﬁcant involvement of TFIIB in
the establishment of directionality (31). The sequence 5 to the
RTATA box does not closely resemble the human or archaeal
BREs, and a BRE has yet to be identiﬁed for S. cerevisiae RNA
polymerase II promoters (R. Ebright, personal communica-
tion). Therefore, we propose that the promoters used in our
analysis lacked a functional BRE and consequently allowed us
to detect expression from the RTATA sequence. Interestingly,
in a different study, TBP-A100P was identiﬁed in a genetic
screen for suppressors of a yeast TFIIB mutant defective in
DNA binding (9a).
In summary, using a genetic approach, we investigated the
contributions of two amino acids in yeast TBP to transcription
directionality in vivo. Our results indicate that Pro191 and
Ala100, which deﬁne a signiﬁcant break in the symmetry of the
TBP-TATA interface, play crucial roles in facilitating DNA
binding and determining speciﬁcity. Consistent with the mod-
est intrinsic preference of wild-type TBP for the transcription-
ally relevant binding orientation, our results indicate that a
single amino acid change on the DNA binding surface of yeast
TBP can allow recognition of a reversed TATA sequence.
Further genetic studies employing reporter constructs such as
those described here may uncover additional regions of TBP
that govern the directional assembly of the preinitiation com-
plex.
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